Shopify vs. WELL Health: Which Is the Better Buy?

Trying to decide between two high-flying growth stocks? Find out which stock is a better buy between Shopify and WELL Health Technologies.

| More on:

Growth investing is difficult. There are many trends that investors need to keep track of, deciding which ones will provide the best opportunities for growth. Within those different trends, investors also need to determine which companies are leading their respective industries today and whether various companies will be leaders in the future. Shopify (TSX:SHOP)(NYSE:SHOP) and WELL Health Technologies (TSX:WELL) are two leaders in their respective industries. Which stock is the better buy today?

Which industry has more room for growth?

The e-commerce industry is a very exciting one. Consumers have slowly adopted online retail over the past two decades, but global penetration has really reached a new level over the past two years. In 2020, the COVID-19 pandemic caused physical retailers to close their doors, pushing more consumers towards online stores.

In Canada, online retail accounted for about 10% of all retail sales in 2020. Meanwhile, in other regions like the U.K., e-commerce represented nearly 40% of all retail sales. There is a lot more room for this industry to run in Canada and in other countries around the world.

The telehealth industry could be just as intriguing. From 2021 to 2026, the telehealth industry is forecasted to grow at a compound annual growth rate of 26.5%. That means that the companies that help lead this industry forward could see massive growth.

We saw how quickly companies like WELL Health and Teladoc were able to grow in just one year. The downside with investing in telehealth stocks is that it may take longer to see it really change health care visits globally. That means, while these stocks could see a lot of growth, it may take longer to see an inflection point in this industry and massive gains in these stocks.

Edge: e-commerce, Shopify.

Assessing company management

Shopify’s management team is very impressive. Its CEO Tobi Lütke founded the company and was even the person who wrote the very first line of code in what would become Shopify’s platform. He is very well-liked at the company, with a 90% approval rating on Glassdoor. Lütke has previously stated that he asks his board of directors each year whether they still believe he is the best individual for the job. If the answer is ever no, he would gladly step aside and let someone else run the company.

To add to the Shopify argument, investors need to be made aware of Harley Finkelstein. A true example of entrepreneurship, he has experience as a merchant, running a t-shirt business to help fund tuition for law school. Finkelstein eventually joined Shopify and became the company’s chief platform office and later its chief operating officer. In September 2020, he was elevated to his current role as Shopify’s president.

WELL Health’s CEO Hamed Shahbazi is an excellent executive, with more than 20 years of experience as a technology-focused operator. Prior to joining WELL Health, he founded TIO Networks, which eventually became a multi-channel payment solution provider.

In 2017, TIO was acquired by PayPal for $304 million. With extensive experience with mergers, acquisitions, and divestitures, Shahbazi is the perfect man for the job to follow WELL Health’s growth playbook.

Edge: While Shahbazi is certainly a top executive, it’s hard to bet against Shopify’s one-two punch of Lütke and Finkelstein.

Head-to-head company performance

When it comes to company performance, Shopify may be one of the most impressive stocks in the world. In terms of its quarterly revenue, Shopify reported year-over-year increases of 110% and 57% in Q1 and Q2 2021 respectively. From 2019 to 2020, Shopify’s annual revenue increased an astonishing 86%. These numbers have been reflected in Shopify’s stock performance, which has gained 93.6% per year on average since its initial public offering.

WELL Health has not yet reported earnings for Q2. However, for Q1, the company reported that its quarterly revenue had increased 150% year over year. This growth was led by a 345% increase in its software and services revenue. Prior to listing on the TSX, WELL Health was named to the TSXV 50 for three years. This is a list of the top 50 performing stocks on the TSXV.

Edge: Even. Both companies are growing remarkably and have a history of strong growth.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jed Lloren owns shares of Shopify and Teladoc Health. The Motley Fool owns shares of and recommends PayPal Holdings, Shopify, and Teladoc Health. The Motley Fool recommends the following options: long January 2022 $75 calls on PayPal Holdings, long January 2023 $1,140 calls on Shopify, and short January 2023 $1,160 calls on Shopify.

More on Tech Stocks

space ship model takes off
Dividend Stocks

2 Stocks I’d Avoid in 2025 (and 1 I’d Buy)

Two low-priced stocks are best avoided for now but a surging oil bellwether is a must-buy.

Read more »

Canada national flag waving in wind on clear day
Tech Stocks

Trump Trade: Canadian Stocks to Watch

With Trump returning to the presidency, there are some sectors that could boom in Canada, and others to watch. But…

Read more »

ways to boost income
Tech Stocks

2 Stocks to Help Turn $100,000 Into $1 Million

Do you want to turn $100,000 into $1 million quickly? Look for small- or mid-cap stocks that are scaling as…

Read more »

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »